ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

HEMO Hemogenyx Pharmaceuticals Plc

1.281
-0.029 (-2.21%)
01 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Hemogenyx Pharmaceuticals Plc LSE:HEMO London Ordinary Share GB00BYX3WZ24 ORD GBP0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.029 -2.21% 1.281 1.252 1.31 1.29 1.25 1.29 2,911,169 16:35:10
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -6.69M -0.0050 -2.50 16.77M
Hemogenyx Pharmaceuticals Plc is listed in the Finance Services sector of the London Stock Exchange with ticker HEMO. The last closing price for Hemogenyx Pharmaceuticals was 1.31p. Over the last year, Hemogenyx Pharmaceuticals shares have traded in a share price range of 1.25p to 6.30p.

Hemogenyx Pharmaceuticals currently has 1,341,815,988 shares in issue. The market capitalisation of Hemogenyx Pharmaceuticals is £16.77 million. Hemogenyx Pharmaceuticals has a price to earnings ratio (PE ratio) of -2.50.

Hemogenyx Pharmaceuticals Share Discussion Threads

Showing 2751 to 2768 of 13450 messages
Chat Pages: Latest  118  117  116  115  114  113  112  111  110  109  108  107  Older
DateSubjectAuthorDiscuss
27/4/2020
18:33
Time for domestos dave to move on to troll some other stock.
It's game over for him here.

on target
27/4/2020
18:17
Have a read of the post over on lse board , Posted at 17.43 pm .
stevehuges
27/4/2020
18:00
Bye Dave..yesterday's man
johntopdog
27/4/2020
17:57
I love the irony that you lot are only making any money doing exactly what I've been telling you to do all along.

You couldn't make it up.

Well done, from learning from me 😂

davevt
27/4/2020
17:29
For the third time, 2k was all I could buy at 1.6 when I put an order in...

Do you grasp this yet? 😂

davevt
27/4/2020
17:26
Sounds like John hasn't made any money 😂😂
davevt
27/4/2020
17:21
If Hemo develop this test to show who is high risk and who is low risk of serious Covid-19 reaction, it may also be useful for use in patients undergoing Car-T cancer treatments by predicting which patients are most at risk from suffering cytokine release syndrome side effects (similar to Covid-19) before undergoing the therapy.

With Car-T therapies curing cancers and slowly becoming 1st line treatment it's quite exciting to be in this space.

asat91
27/4/2020
17:16
Small trader....guys, trading is just pocket money...😅



My cars depreciate more a month than you lot make 😂

davevt
27/4/2020
17:14
Probably hit 5p in first few minutes tomorrow

Wins will probably mark it up to 4.6p and there's unlimited chasers in this market.

It was bonkers below 2p and 7 mil cap when other stocks in this sector had market cap many multiples of this.

It was a spike waiting to happen

dave4545
27/4/2020
17:14
'As part of its studies, Hemogenyx will transplant cells from blood samples from patients who are either recovering or have already recovered from COVID-19 into its ApbHC humanized mice. The process will allow the Company’s scientists to recreate a set of anti-SARS-CoV-2 virus antibodies which could be used for the treatment of COVID-19.

In addition, the study will aim to demonstrate how Hemogenyx’s technology can be deployed rapidly in emergencies in order to discover human neutralizing antibodies against a host of viral pathogens, including what infectious disease experts in the bioprotection and biodefense sectors call “Disease X”, meaning as-yet unknown viruses that may represent a similar or greater threat than the one presented by COVID-19.

Concurrently, Hemogenyx has initiated a pilot study to understand why some individuals who are infected with SARS-CoV-2 are asymptomatic, some exhibit mild symptoms, and some become very sick and even die. Such understanding could prove essential for both the development of new treatments for COVID-19 and managing the current risk of infection. Should the study prove to be successful, Hemogenyx will aim to develop and commercialize a test that would prospectively identify people with potentially high/low risk of severe illness caused by the virus.'

asat91
27/4/2020
17:06
dont try and talk away the damage you would've made nearly 4 grand more.i saw your ticket!bad luck.

maybe trading isn't for you?

purple11
27/4/2020
17:06
Dave...let me correct you...if you had sold today you would have made another £4k profit.....ouch that gotta hurt for a small trader..

The train is leaving the station and you are just waving us all goodbye...

See ya loser...enjoy your tea...egg and soldiers for you !

johntopdog
27/4/2020
17:05
Wow just seen the NCYT rise never seen anything like that before - looks like the entire rise is because of the contract with government to provide CV-19 tests.
asat91
27/4/2020
16:57
Very strange rise considering no concrete news out. Just a big buyer I guess
asat91
27/4/2020
16:47
It's mental at the moment. Look at ncyt share price 4p to £5 in a few weeks . Could are mice hold the key to unlocking the code . Good luck all
stevehuges
27/4/2020
16:46
Watch it open up in the morning. Well done all who got in below 2p. So much more coming here.
intheknow69
27/4/2020
16:44
Congrats on your profit LH; money in the bank is rarely a bad decision
asat91
27/4/2020
16:43
just wish it was more gradual and not one enormous spike.makes me nervous....
purple11
Chat Pages: Latest  118  117  116  115  114  113  112  111  110  109  108  107  Older